Seysara

Chemical Namesarecycline
Dosage FormTablet (oral; 60 mg, 100 mg, 150 mg)
Drug ClassTetracyclines
SystemSkin
CompanyAlmirall
Approval Year2018

Indication

  • For the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older
Last updated on 4/20/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Seysara (Sarecycline) Prescribing Information.2018Allergan USA, Inc., Madison, NJ